The digital diabetes management market is expanding as healthcare providers and patients increasingly adopt connected technologies for diabetes monitoring, treatment support, and disease management. Digital solutions can help improve access to glucose data, encourage patient engagement, and support more informed healthcare decisions.

Market Size and Growth

The digital diabetes management market was valued at approximately US$ 15.28 billion in 2025 and is projected to reach nearly US$ 30.95 billion by 2034, expanding at a CAGR of approximately 8.16% during 2026–2034.

The expansion of the market is closely associated with the increasing adoption of digital health technologies for diabetes care. Connected glucose monitoring devices, mobile applications, digital platforms, and remote patient management solutions are enabling patients and healthcare professionals to access and evaluate diabetes-related information more efficiently. The growing emphasis on continuous disease monitoring and personalized care is further supporting adoption.

Get Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00003092

Increasing Prevalence of Diabetes

The rising prevalence of diabetes worldwide is one of the primary factors driving demand for digital management solutions. Diabetes requires continuous monitoring and long-term management, creating a need for technologies that can support patients beyond periodic clinical consultations.

Traditional approaches to diabetes management can require patients to manually record glucose readings, medication information, food intake, and physical activity. Digital platforms can simplify several of these activities by collecting and organizing information electronically. This can provide patients with a clearer understanding of their health trends while enabling healthcare professionals to evaluate relevant information during consultations.

The increasing focus on early intervention and improved glycemic management is also encouraging healthcare organizations to explore connected technologies that can complement conventional diabetes care.

Growing Adoption of Connected Glucose Monitoring

Connected glucose monitoring is an important component of digital diabetes management. Modern technologies can collect glucose measurements and transmit relevant information to digital platforms, allowing patients and healthcare professionals to monitor trends more efficiently.

Continuous glucose monitoring and connected devices can provide more frequent information than traditional periodic measurements. This availability of data can help users identify patterns and support discussions with healthcare professionals regarding lifestyle, medication, and treatment management.

Integration between monitoring devices and mobile applications is further improving convenience. Patients can increasingly access relevant information through smartphones and other connected devices, supporting more active participation in their own care.

Role of Mobile Applications and Digital Platforms

Mobile applications have become an important part of digital diabetes management because smartphones provide a convenient platform for accessing health information. Diabetes applications can support activities such as glucose tracking, medication reminders, dietary monitoring, physical activity management, and communication with healthcare professionals.

Digital platforms can also aggregate information from multiple connected devices. Combining glucose readings with other health and lifestyle information can provide a broader picture of disease management and help support more personalized care strategies.

The increasing penetration of smartphones, connected devices, and digital health platforms is therefore creating favorable conditions for continued market growth.

Remote Patient Monitoring and Telehealth

The expansion of telehealth and remote patient monitoring is another important market opportunity. Digital diabetes management technologies allow healthcare professionals to monitor selected patient information without requiring every interaction to occur in a clinical setting.

Remote monitoring can support patients who require regular follow-up while reducing the need for frequent in-person visits. Healthcare professionals can use digitally collected information to identify trends and determine whether additional consultation or intervention may be appropriate.

This approach is particularly relevant to long-term diabetes management, where consistent monitoring and patient engagement are essential components of care.

Artificial Intelligence and Data-Driven Diabetes Care

Artificial intelligence and data analytics are creating additional opportunities within digital diabetes management. As connected devices generate larger volumes of health data, advanced analytics can help identify patterns and provide meaningful insights from collected information.

AI-enabled platforms can support predictive analysis, risk assessment, personalized recommendations, and clinical decision support. These capabilities can potentially help healthcare providers identify changes in patient conditions earlier and support more individualized approaches to diabetes management.

Integration of AI with connected monitoring technologies is expected to remain an important area of innovation as developers seek to improve the usefulness and efficiency of digital health platforms.

Market Opportunities and Challenges

The expansion of digital healthcare infrastructure is creating opportunities for technology providers, medical device manufacturers, software developers, and healthcare organizations. Integration of digital tools into established diabetes care pathways can expand access to monitoring and improve communication between patients and providers.

However, factors such as data privacy, cybersecurity, interoperability, technology costs, and differences in digital health infrastructure can influence adoption. Ensuring that digital platforms are easy to use and compatible with existing healthcare systems remains important for broader implementation.

Competitive Landscape

The digital diabetes management market includes medical technology companies, pharmaceutical and healthcare organizations, connected-device manufacturers, and specialized digital health companies. Competition is increasingly focused on device connectivity, software capabilities, data integration, patient engagement, and personalized disease management.

Key players include:

• Medtronic plc
• F. Hoffmann-La Roche AG
• Glooko, Inc.
• Omada Health, Inc.
• B. Braun Melsungen AG
• Abbott Laboratories
• Insulet Corporation
• Tandem Diabetes Care, Inc.
• Ascensia Diabetes Care Holdings AG
• Smart Meter, LLC

Companies are investing in connected technologies and digital platforms designed to improve monitoring, data accessibility, and patient participation. Partnerships between technology providers and healthcare organizations can also support integration of digital solutions into broader diabetes management programs.

Future Outlook

The future outlook for the digital diabetes management market remains positive through 2034, supported by the increasing need for continuous diabetes monitoring and the broader adoption of connected healthcare technologies. The integration of glucose monitoring devices, mobile applications, remote patient monitoring, and data analytics is expected to strengthen digital approaches to long-term disease management.

Artificial intelligence is likely to remain an important area of development, particularly as healthcare providers seek to derive actionable insights from increasingly large volumes of patient-generated data. Improvements in interoperability can also enable information to move more efficiently between connected devices, digital platforms, and healthcare systems.

As diabetes management increasingly emphasizes continuous monitoring, patient engagement, personalized care, and remote interaction with healthcare professionals, digital technologies are expected to play an increasingly important role in supporting efficient and data-driven diabetes care.

Related Reports @

Diabetes Monitoring Devices Market Size, Demand & Growth by 2034

Glucose Monitoring Devices Market Size and Competitive Analysis by 2030

About Us –

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean German Japanese French Chinese Italian Spanish